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INTRODUCTION
1INTRODUCTION
Candidiasis  refers to a diverse group of  infections caused by the yeasts
of genus Candida which have been known for centuries. These organisms
usually cause superficial infections involving the skin, nail, mucous membrane
but can also produce serious systemic infections like septicemia, endocarditis
and meningitis   in immunosuppressed individuals.[1]
           Candida species constitute a part  of the normal  flora of the  digestive
system and the female genital tract. Colonization with these organisms may
occur during  birth or later in life[1,2] . In healthy individuals, such colonization
is asymptomatic and their overgrowth is limited by the immune system and
other bacteria occupying the gastrointestinal tract and vagina .When the
immune system is deranged or an alteration in the ecology occurs, there is
overgrowth of these organisms  producing  infection.[1,2]
There are over 200 species of Candida till date and their epidemiology is
constantly changing  with varying  clinical patterns, virulence and antifungal
susceptibility.[2]
REVIEW OF LITERATURE
2REVIEW OF LITERATURE
HISTORY
The history of  discovery and naming of  Candida dates from the ancient
Greeks to modern day researchers.
           Around 400 BC, Hippocrates in “Of the Epidemics ” described oral
candidiasis, the first form of  the disease as “the mouth affected with aphthous
ulceration ” [3,4].The first description of thrush in modern medicine were made
by   Rosen Von Rosenstein and Underwood in 1771.The word “thrush” derived
from ancient Scandinavian or Anglo-Saxon words was used to denote
candidiasis .The  French used the term “le Muguet” which means ‘lilly-of-the-
valley’ to describe this condition.In 1835,Veron first described the case of
oesophageal candidiasis and postulated that newborns acquire it during passage
through the vagina. In 1839, initial discovery was made when Langenbeck
observed a fungus in scraping of oral  thrush from a patient with typhus [5,6].
The correct association of oral thrush and its mycotic pathogen was made in
1842 by Gruby who classified the microorganism as Sporotrichum species.[1]
           In the subsequent years, various pathological conditions were shown to
be associated with Candida. In 1842, Bennett isolated  the fungus from the
sputum of tuberculous patient.  Following  his work, Wilkinson (1849) isolated
it from vaginal candidiasis while Robin (1853) isolated it  from a patient with
systemic infection.
3The dimorphic nature of the fungus, the budding yeast form, the
mycelial form and chlamydospores was noticed by Grawitz in 1877.[2] In 1886,
the genus “Monilia” included certain filamentous fungi isolated from rotting
fruits and leaves as defined by Saccardo. In  1890, Schmorl reported a case of
disseminated candidiasis involving many organs. In the same year, Zopf
named the fungus Monilia albicans from which moniliasis, the early name of
Candidiasis originated. Torulopsis glabrata was first isolated from grapes in
1894 by Berlese and was described in humans by Anderson in 1917.[1]
In 1912, Aldo Castellani was the first to suggest the possibility of
Candida species other than Candida albicans while describing “tea taster’s
cough”. In 1923, Berkhont established the Genus Candida to accommodate
“monilia” and defined it to include anascosporogenous yeast species that
develop pseudohyphae. This was later accepted as the official name of the
genus by the Eighth Botanical Congress held in Paris  in the year 1954.[5] In
1959, the species Candida viswanathii was designated in honour of
Dr.Viswanathan, the first director of the Vallabhbhai patel chest
institute(VPCI), Delhi. In 1995, Candida dublinensis was described as new
species by Sullivan and colleagues from Dublin, Ireland. These events in
conjunction  with the biological techniques, has helped in extensive research
into the newer species, pathogenetic mechanisms, new concepts in diagnosis
and treatment with increasing demands for newer antifungal agents with fewer
side effects. In the last decade, there had been major changes in the
epidemiology, clinical spectrum and fungal susceptibility.[1,2]
4FUNGAL CHARECTERISTICS OF THE ORGANISM
Candida belong to the class of  blastomyces under the order
Cryptococcales .There are over 200 species identified of which Candida
albicans has been considered as the pathogenic organism. Other non Candida
species of pathogenic significance include Candida tropicalis, Candida
glabrata (previously Torulopsis glabrata), Candida kefyr (previously
pseudotropicalis), Candida dublinensis, Candida krusei,Candida parapsilosis,
Candida guillermondii, Candida viswanathii, Candida lusitaniae and Candida
zeylanoides. Candida albicans is an oval  yeast  measuring 2-6 micron x 3-9
micron in size which  exhibits polymorphism producing various  morphological
forms such as budding yeast cells, pseudohyphae  and  true hyphae.[1]
GROWTH CHARACTERISTICS
Candida grows easily in Sabouraud’s dextrose agar at 370 C at room
temperature within 24-48 hrs. The morphology of the colonies and their growth
in various medias like Sabouraud’s dextrose agar, corn meal agar and chorme
agar may vary according to the species.[1,2]
Candida  albicans:
On Sabouraud’s dextrose agar, the colonies are cream colored and
smooth. In corn meal agar, the colonies are large with thick walled
chlamydospores.[1]
5Candida tropicalis:
On Sabouraud’s dextrose agar, the colonies are cream colored, smooth,
wrinkled with mycelial fringe. In corn meal agar, it produces blastoconidia
singly or in very small groups all along  the long pseudohyphae.[1]
Candida krusei:
On Sabouraud’s dextrose agar, the colonies are dull, dry and wrinkled.
In cornmeal agar, pseudohyphae with blastoconidia forming crossed match
stick appearance are seen. Positive Urease test is specific for the species and  is
indicated by a purple pink or red color in Christensen’s urease medium.[1]
Candida parapsilosis
On Sabouraud’s dextrose agar, the colonies are cream colored, shiny and
smooth. In corn meal agar, short pencil like pseudohyphae with blastocondia
arranged singly along the pseudohyphae are seen[1]
Candida glabrata
The colonies on Sabouraud’s dextrose agar are cream colored, smooth,
soft and they produce no pseudohyphae.[1]
Candida dublinensis
Rough colonies with abundant chlamydospores are produced in
Saboraud’s dextrose agar. They are unable to grow at 450 c and in 6.5% sodium
6chloride, unlike C.albicans. Sunflower seed husk agar can be used for the
differentiation of C.dublinensis  from C.albicans.[7,8,9].
EPIDEMIOLOGY OF CANDIDA SPECIES
The yeast of genus Candida have been the fourth most common primary
pathogen in blood stream and seventh most common pathogen in nosocomial
infection.[2] Candida infection constitutes 15% of hospital acquired illnesses,
72% of nosocomial infection and 8-15% of all nosocomial candidemia in
critical care.[18,19,20]
Candidiasis can affect all age groups  with differing data from various
parts of the world. Neonatal superficial and systemic candidiasis have become
increasingly prevalent in ICU units.[21,22] Postnatal acquisition has been
attributed to increased number of invasive procedures and widespread use of
broad spectrum antibiotics . Candidal infection in the elderly are attributed to
poor self care, decreased salivary flow rate associated with ageing and intake of
high dose of cytotoxic drugs for malignant diseases. Although superficial
infections are thought to be benign, significant morbidity can occur.[21,22]
The highest proportion of C. albicans was found in North and Central
Europe and the USA. Non-albicans species were more common in South
America, Asia, and South Europe.[1,2,21] C. glabrata was commonly isolated in
the USA and North and Central Europe; C. parapsilosis in South America,
South Europe, and several parts of Asia; and C. tropicalis in South America
and Asia. The relative frequency of C. krusei was low in all regions.[1]Most of
7the Candida spp are isolated from the animal and other environmental sources .
Candida albicans is considered as the major pathogen but the incidence of non
albicans species is increasing  since the last decade with the advent of newer
immunosuppressives and HIV pandemic.[1,2,21]
With the exception of Candida albicans, which is the only endogenous
yeast, all others are exogenous in origin with the sources including soil, air,
water, plants, dairy products and fermenting plant products.[1,2]
In humans, Candida spp inhabits the gastrointestinal tract and
vulvovaginal area. Colonization  begins during  birth  directly  from  the birth
canal sometimes during infancy or during later life. Candida albicans is
implicated in both superficial and deep infections. Candida parapsilosis is
found in skin, C.kefyr and C.tropicalis in the respiratory tract.[1,2]
           There has been a change in the trend worldwide. There are increasing
reports of Candida tropicalis in Indian studies in bloodstream infections. It is
also the major cause of septicemia and disseminated candidiasis especially in
lymphoma, leukemia and diabetes. [1,2,23]Candida krusei is regularly associated
with some form of infant diarrhea and occasionally associated with systemic
disease. It has also been reported to colonize the gastrointestinal tract,
respiratory and urinary tracts of patients with granulocytopenia. Environmental
isolation have been made from, skin and feces of animals and milk products.[1,2]
Candida parapsilosis is an opportunistic human pathogen which may
cause both superficial cutaneous infections especially of nails and systemic
disease especially endocarditis and also endopthalmitis. It specifically produces
8onychomycosis which is capable of adhering and growing as biofilm on human
nail surfaces. Nails also act as the reservoir of this infection.[23]. It is also a
contaminant of  high concentration glucose solution and prosthetic material.[1]
Candida glabrata is one of the isolates from oral cavity, denture
stomatitis and vaginitis which has intrinsic resistance to fluconazole.[1]Candida
kefyr is less common which has been isolated from vaginal, urinary, ear and
gastrointestinal infections. Candida viswanathii has been isolated from India in
clinical specimens and from the environmental sources in South
Africa.[1]Candida krusei and C.glabrata fungemia is associated with previous
exposure to azoles[24]
Few reports show positive correlation of candidial infection with certain
blood group. Infection are increased in patients with non A group especially O
blood group patients. The commonest yeast isolated is Candida albicans from
all blood groups patients. Candida krusei has been found to colonise only in
AB group patients. Blood group A patients show isolates of Candida albicans
and Candida tropicalis. The exact mechanism for the susceptibility is not
known. It is postulated that a blood group substance may play a significant role
in host response to fungal infections by virtue of their cross reactivity with
surface antigens on these fungal cells.[25]
9PATHOGENESIS
Most infections of Candida albicans are endogenous and generally
follows a shift in host- mycelial relationship. This shift from commensal to
parasite results from a variety of influences which are as follows.
Microbial factors
a)Adherence: The ability of the yeast forms to adhere to the underlying
epithelium is important for tissue invasion. It is dependent on many factors like
presence of other microorganisms that may compete for cellular binding sites,
nutrients like glucose, hormones like estrogen and presence of  IgA . Cell
surface hydrophobicity is important for adherence. Germ tube formation
increases the cell surface hydrophobicity. Initial adherence is dependent on
unidentified receptors, adhesins related to fibronectin , mannoprotein and other
proteins.Candida albicans has the maximum adherence capacity followed by
Candida tropicalis and Candida parapsilosis.[2,10]
b) Enzymes :  There are about fourteen hydrolytic enzymes of which few are
important for pathogenesis like, proteases, lipases, esterases, phosphatases and
phospholipases. Secretion of serine aspartyl proteinases and serine proteinases
facilitates the hyphal invasion especially in disseminated candidiasis.[2]
c)Invasion: Germ tube  formation  potentiates  invasion  by production of
various enzymes. Proteinases are known to break down peptide bonds, of
which aspartate proteinases are collagenolytic. Phospholipases enhance
10
invasion, of which carboxyl phospholipases are proteolytic to keratinocytes.
These cause cell damage, swelling, erythema, desquamation, exfoliation and
development of an acute inflammatory reaction. Secreted aspartate
transaminases break down immunoglobulins and are important for skin and
mucous membrane infection. Increased virulence of C.tropicalis isolates was
observed when given orally to compromised mice, which parallels clinical
observations in immunocompromised patients.   Some studies have shown that
C. tropicalis is even more invasive than C.albicans in the human intestine,
particularly in oncology patients. Secreted aspartyl proteinase 5 and 9 (SAP5
and SAP9) activity occurs in all Candida species, in the following order:
C.albicans>C.tropicalis>Candida kefyr>Candida krusei.[10]
The aspartic proteinases secreted by C.tropicalis have also been
demonstrated on the surface of the fungal cell walls before invading
macrophages and tissues during disseminated infections. Some nonalbicans
species that were previously thought to be SAP negative were infact
proteolytic. The purified tropiase from C. tropicalis (a novel acid proteinase)
demonstrated the ability to increase capillary permeability and haemorrhagic
activity. C.albicans and C.tropicalis produced marked levels of prostaglandins,
while C.glabrata produced a very low level. Clinical and experimental
observations suggest that morbidity and mortality rates are higher due to C.
tropicalis infection than due to C. albicans infection. These findings support
the hypothesis that there must be some additional C.tropicalis secretory
products that are probably more pronounced in a T-cell-deficient host. Such
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secretory products from C.tropicalis could be intensely cytotoxic or there could
be synergistic interactions with the host cells that culminate in the deaths of
immunocompromised patients. Recent studies on three specific key virulence
factors such as proteinase, phospholipase and biofilm formation suggest that
the detection of hydrolytic enzymes and the ability of Candida yeasts to form
biofilm may be useful indicators of possible haematogenous infection. Such
findings may support clinicians in the management of patients who have a high
risk of haematogenous Candida infections.
d) Candida Antigens: The antigenic structure of Candida are primarily for the
identification of Candida species. They are broadly classified into cell wall
antigens and cytoplasmic antigens. The cell wall of candida is composed of
glucan polymers which are in abundance and mannans. Mannoproteins are the
major antigenic determinants. The cell wall is not antigenically consistent as
they are bound to change according to the growth characteristics.. The alpha-D-
mannan of the cell wall of Candida spp is an important constituent of its
structure as it acts as a major antigen. The mannan usually has a (1 -6)-linked
main backbone with side chains containing (1-2) or (1-3) linkages.[2]Certain
antigens are also known to be derived from the cytoplasmic components.
e)Phenotypic switching: The ability of the organism to switch to different
morphological forms such as unicellular budding yeast to filamentous
pseudohyphae and true hyphae assists the fungus in evading the host defence
and also contributes to the virulence of the organism. This is analogous to
phase variation in bacteria.
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f)Others: The glycoprotein extracts of Candida cell wall are analogous to
bacterial endotoxins which are lethal and can cause anaphylactic shock . The
ability to bind complement receptors may also contribute for the virulence. A
wide variety of   other factors like temperature above 350C, low oxygen
tension, liquid media, non sulphur containing aminoacids, a polysaccharide
carbon source, serum and a pH of 7.5 may also contribute for the
pathogenesis.[10,,11,12]
HOST FACTORS[13]
a)Endogenous factors : Age plays an important role in newborn particularly
premature and also in the elderly. Low birthweight infants are highly
susceptible to systemic candidiasis. Severe cachexia and debilitating diseases
like diabetes mellitus and malignancy are prone for candidiasis. Endocrine
disorders like hypoparathyroidism, adrenal insufficiency and Cushing’s disease
favour candida infection. Immunodeficiency states like Acquired
immunodeficiency states, Severe combined immunodeficiency disorder,
Myeloperoxidase deficiency, Chediack Highasi syndrome, Hyperimmuno
globulinemia E syndrome, Chronic granulomatous diseases, DiGeorge
syndrome and Nezelof syndrome may increase the incidence of superficial and
systemic candidiasis[12,13]
b)Exogenous factors : The various  predisposing factors for candida infection
are trauma, local occlusion, moisture, dentures and obesity. Nutritional
deficiencies like Avitaminosis, iron deficiency and generalized malnutrition,
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iatrogenic factors like indwelling catheters, exposure to X-ray irradiation,
administration of glucocorticoids, immunosupressives, antibiotics, oral
contraceptives, colchicine, and phenylbutazone are also considered as
important factors that make the patient susceptible to the infection[13]
Immunology of candidal infection:
Most of the clinical manifestations are due to the deficiency or
dysfunction of the innate and the adaptive immune systems. Both innate and
humoral immune system work cooperatively to provide an effective defence
against the invading yeasts.[13]
Innate immune system
The normal innate immune system against Candida  include intact skin
and mucosa and nonspecific humoral factors. The first line of defence that
protects against the mucocutaneous form of the disease is the unbreached skin.
The risk factors that increase the susceptibility of the disease  by compromising
the skin integrity includes maceration, trauma to the skin and mucosa and
excess of carbohydrates on the surfaces. Additional nonspecific features
include iron binding proteins transferrin and lactoferrin[13,14].
           The second line of defence after penetration of the fungus  include the
phagocytic cells and the candidicidal activity of the polymorphonuclear cells.
These processes include myeloperoxidase and superoxide or cationic
proteins.[12,13,14]
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Cell mediated immunity(CMI):
This plays an important role in host defence against Candida
infections.Patients with defective cell mediated immunity develop only
mucocutaneous disease whereas dysfunction of neutrophils leads to systemic
involvement.[14,,15]
Candida infection of epithelial cells (EC) results in a series of events
like increase in matrix metalloproteinases, which plays a role in remodeling of
the epithelium, modulation of barrier function, upregulation of antimicrobial
peptides, beta defensins and IL-37 which have anticandidicidal activity,
playing a significant role in combating infection and invasion.[15] Phagocytic
cells engulf the yeast and destroy it by respiratory burst and cytokine release.
The antigen presenting cells process the candida antigens and migrate to the
lymph nodes to present them to the naïve T cells in the lymph nodes which are
then activated and differentiate into Th1 and Th17 effector cells. On reaching
the effector site, Th1 cells release cytokines that orchestrate containment of
infection to the mucosal surfaces and prevent dissemination.Th17 effector cells
release IL 17 and IL 23 which have a complementary role in induction of T cell
responses to infection. IL 23 is essential for the polarization of Th17 cells and
IL 17 is required for the production of inferon gamma which is essential for
Th1 response.[14,15,16]
Neutrophils are the predominant cell type which prevents deep seated
infections[1]
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HUMORAL IMMUNITY
Although patients with immunoglobulin deficiency are not particularly
suscepitible humoral immunity does play a role in protection against candidal
infection. The high levels of IgA  found in infected subjects doesnot prevent
colonization . Hence, there is no role for the use of immunoglobuins as a
treatment modality.[16]
IgG and IgM are increased in deep seated infections except in
immunosuppressed individuals who are unable to mount an immune response.
Anti IgE antibodies are found in patients with allergy. Skin inoculation of the
antigen results in flare  like erythema at the site of inoculation immediately
after the test.[15,16]
           Recent studies have  shown strong evidence of a persistent immunity
resulting  from a primary infection mediated by antibodies of definite
specificity. The nonsecretors of lewis blood group are particularly susceptible
to Candida infection.[16]
CLINICAL SPECTRUM OF CANDIDIASIS
           The clinical spectrum of candidiasis is extremely varied, ranging from
acute, subacute, chronic and episodic.[2] Involvement may be localized to skin
and mucosa or it may be systemic as in septicemia, endocarditis and
meningitis. The pathologic response evoked is diverse and vary from irritation
and inflammation to chronic and acute granulomatous response.[2,16]
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Oral candidiasis
Oral candidiasis is the most common type of candida infection in
clinical practice.The development of infection depends on the epithelial barrier
function, salivary flow rate, dentures, poor oral hygiene, antimicrobial
constituents of saliva, presence of normal microbial flora and local immunity.
Patients with decreased salivary flow rates as in conditions like Sjogren’s
syndrome and prolonged antimicrobial therapy that alters the microbial flora
makes the patient vulnerable. Saliva is rich in Antimicrobial peptides, defensins
and histatins which are protective. Defects in dectins 1&2, the NOD like
receptor, pyrin domain containing 3 inflammosome and caspase recruitment
domain family  member 9 cause defective activation of Th17 cells and IL 23
increasing the likelihood of oropharyngeal candidiasis.[1]The various clinical
patterns are as follows:
? Acute pseudomembranous candidiasis otherwise called as oral
thrush is characterized by sharply defined patch of creamy, crumbly,
curd like white pseudomembrane which when removed leaves an
erythematous base.[26]
? Acute erythematous candidiasis is also as called acute atrophic
oral candidiasis or antibiotic sore throat characterized by marked
soreness and denuded atrophic erythematous mucous membrane,
particularly on the dorsum of tongue. It is especially commonin patients
on prolonged antibiotic therapy.[26]
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? Chronic pseudomembranous candidiasis is similar to acute
pseudomembranous type but it is persistent principally occuring in
immunocompromised persons.[26]
? Chronic erythematous candidiasis which  is also called as
denture sore mouth occurs  in persons with orthodontic appliances and is
confined to the upper denture bearing areas, the palate and gums
characterized by shiny atrophic epithelium with marked erythema.[26]
? Chronic plaque candidiasis is also called as hyperplastic
candidiasis and is characterized by persistent, firm, irregular white
plaques in the mouth on the cheek or the tongue which is not easily
removed . Most of  the patients are men over the age of 30 years. No
predisposing factors are found. This condition has to be differentiated
from oral leukoplakia which is a premalignant condition. Although the
affected areas may undergo malignant change, it may eventually clear
with appropriate anticandida therapy.[26]
? Chronic nodular candidiasis is a rare form which presents with
cobbled appearance of the tongue, most often found in association with
chronic mucocutaneous candidiasis.[26,27]
? Angular cheilitis (Angular stomatitis; Perleche) is
characterized by soreness of the angle of the mouth extending outwards
in the folds of the facial skin which is due to mechanical factors like
18
increased depth of the fold, malocclusion, malnutrition, due to persistent
lip licking and increased salivation[26,28]
? Median rhomboid glossitis is a variant of chronic plaque like
candidiasis with diamond shaped area on the dorsum of tongue with loss of
papilla. This has been noted in denture wearers. Candida grows well in the
midline of the tongue and this area of the tongue  comes in contact with the
palate during swallowing and at rest. “Kissing lesion” on the palate is also
noted. Patients with this infection should be investigated for AIDS. It is also
proposed that impaired blood supply on the dorsum of the tongue might
cause median rhomboid glossitis and loss of filiform papillae.[29,30]
CANDIDIASIS OF GENITAL MUCOUS MEMBRANE
Vulvovaginal candidiasis (Vulvovaginal thrush)
Vulvovaginal candidiasis is the most common cause of vaginal infection
in the tropics and second only to bacterial vaginosis in developing nations.
About 75% of the women will have atleast one episode in lifetime while 40-
50% have recurrences.[31]  In 20% of women, colonization of Candida is
asymptomatic and 4% suffer recurrences. It is 20 times more common than
balanoposthitis.[32,33]
The general predisposing factors include maceration of the skin which is
associated with the use of tight, vinyl cycling pants and non cotton, tight
clothing in the tropics the incidence increases with the usage of vaginal
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sponges and IUCDs.[34] The short term risk factors include use of broad
spectrum antibiotics.[35]Hormonal factors like hormone replacement therapy
and high dose estrogen therapy may predispose to VVC. Oestrogen is
associated with cyclical candidiasis. Progesterone contraceptives and lactation
may be protective. In post menopausal women there may be underlying factors
like uncontrolled diabetes, immunosuppression from HIV, broad spectrum
antibiotic therapy, douching or the use of perfumed, feminine hygiene
products. [36,37]
           The clinical spectrum of disease can be classified as  uncomplicated  or
infrequent VVC and complicated VVC. Uncomplicated and sporadic disease
usually occurs in nonimmunocompromised individuals with no predisposing
factors including pregnancy. These patients have only mild to moderate
symptoms and is usually caused by Candida albicans. Complicated VVC
include recurrent severe VVC with uncontrolled diabetes, debilitation,
pregnancy and immunosuppression and is caused by noncandida albicans
species.[38]
           The patients present with redness, swelling, pruritus with edematous
vulva and adherent white discharge at the introitus and vestibular region. There
may be satellite pustules around the labia and redness and involvement of the
perianal area. Women with post thrush vestibulitis have tender areas around the
hymenal ring particularly between 3 and 9 o clock position. There may be
involvement of the periurethral area and infection of the urinary tract.[36,37,38]
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Few patients have recurrent vulvovaginal candidiasis (RVVC) with 4 or
more episodes of symptomatic disease per year (atleast one episode confirmed
by culture). The predisposing factors are antibiotics, pregnancy, hormone
replacement therapy, oestrogens, diabetes mellitus and tight clothing in
tropics.[38,39] Some studies show association of atopy with RVVC with a high
incidence of  family history of allergies in these patients. There was also
association with skin test positivity to inhalant allergens and to Candida
albicans.[40,41]
Candida balanoposthitis
This is the most common cause of balanitis. There is no significant
difference in the carriage rates between circumcised and uncircumcised men.
Only a few develop symptoms like burning and itching in the penis with small
pustules or papules in the penis which break to leave behind superficial
erosions with collarette of scales  and curdy accumulation under the prepuce. In
circumcised men there may be glazed appearance of the glans with a scaly
edge. Candida balanitis is most frequently confused with irritant balanitis,
circinate balanitis, contact dermatitis  and  plasma cell balanitis.[42,44,]
Candidal Intertrigo (flexural candidiasis)
Inflammation of two opposing skin surfaces is termed intertrigo.
Intertriginous lesions can occur in the groin, webspaces of fingers and toes and
also in submammary region. The classical features are erythema which spreads
beyond the contact area with fringed irregular edge and subcorneal pustules
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rupturing to give tiny erosions and satellite pustules. Other predisposing factors
are obesity, hot humid climate and prolonged use of occlusive foot wear.
Erosio interdigitalis blastomycetica is a form of candidiasis seen as an oval area
of macerated skin on the web extending to the sides of fingers mostly involving
the third web space between the middle and ring finger. Usually at the center of
the lesion, there are one or more fissures with raw red bases. As the condition
progresses the macerated skin peels off leaving a painful denuded area
surrounded by a collar of overhanging white epidermis. In the feet, the clinical
picture is similar but for the fact that white sodden epidermis which is thick
does not peel off freely with the  involvement of fourth web space.[44]
Perianal and scrotal candidiasis
This usually starts around the anal margin with nonspecific erythema,
oozing and maceration with subsequent spread to the natal cleft. Satellite
lesions may or may not be present .Candidial overgrowth is also enhanced on
abnormal tissue such as extramammary paget’s disease or psoriasis. If the
tissue does not return to normal after being treated with anticandidal drugs a
biopsy is warrented. Candidiasis should be excluded in unexplained erythema
of scrotal skin. [45]
Napkin candidosis (Diaper candidosis)
Diaper dermatitis is the most common skin condition  in infants and
constitutes 20% of all dermatitis seen in that age group with no sexual
predilection. The average age at onset is 9-12 months but can occur as early as
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first month. Diaper dermatitis due to candidiasis is characterized by erythema
of the folds with many small erythematous desquamating satellite or daughter
lesions scattered along the edges of the macules. This condition has to be
differentiated from seborrhoeic dermatitis, flexural psoriasis, acrodermatitis
enteropathica and langerhan cell histiocytosis.[45]
Granuloma gluteale infantum
It is a rare clinical entity of unknown etiology and candidiasis is one of
the contributing factors. It presents as multiple cherry red nodules in the diaper
area.[46,47] The diagnosis should be considered in longstanding and
unresponsive  cases of diaper dermatitis. Histopathology shows nonspecific
inflammatory infiltrates of neutrophils, plasma cells, histiocytes and
eosinophils with an overlying epidermis with parakeratosis. There are no
granulomas and hence the name is a misnomer. Granuloma gluteale adultorum
is the name given to similar clinical picture seen in adults.[48,49]
CANDIDA NAIL DISEASE
The main manifestations of candidal nail infection are in the form of
chronic paronychia and onychomycosis.
Candidal paronychia
Chronic paronychia due to Candida is seen mainly among individuals
who immerse their hands frequently in water especially affecting the finger
nails. The nail fold is red swollen with loss of cuticle and detachment of nail
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from the nail plate with intact hyponychium. Thick white discharge can be
expressed from the nail folds. Onchycolysis and dystrophy are also reported but
massive destruction of nails is rare.[50,51] Recent studies have shown that
psoriatic patients with Candida isolates from the nails have high NAPSI
score.[52]
Candidal Onychomycosis
 The primary cause for onychomycosis is dermatophytes while Candida
species is isolated as a second line pathogen. The predisposing factors are
ageing, HIV, Cushing’s disease, Raynaud’s phenomenon, trauma, moisture and
chemicals .There are three main manifestations  of  candida nail infection such
as distal and subungual onychomycosis, erosion of the nail plate and total
dystrophy of the nails. Distal and lateral subungual onychomycosis is
associated with paronychia. Erosion of the nail plate which indicates invasion
of nail plate is a specific feature and is most often found in women. [53] Total
dystrophy of nail is found in chronic mucocutaneous candidiasis.[54,55]
CANDIDIASIS IN SPECIAL POPULATIONS
          Candida infects all age group from infancy to old age. However candida
infection  that need special mention  are those that occur in neonates,
pregnancy and HIV.
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CANDIDA IN PEDIATRIC AGE GROUP
Congenital candidiasis
Congenital candidiasis is a rare entity and around 70 cases have been
reported in the past forty years. This was first reported by Sonnenschein in
1960. It is considered to be an ascending infection through the mother’s birth
canal. The proposed risk factors are maternal age, parity, vaginal candidiasis in
mother, prolonged rupture of membranes, amniocentesis, chorioamnionitis,
foreign bodies like suture materials and IUCD in the uterus. It presents at or
immediately after birth but can occur as late as 6 days of life characterized by
erythematous macules, papules, vesicules and pustules initially over the face
and chest. Oral thrush is absent. Amniotic fluid may be turbid. Few neonates
show dissemination to the lungs with high mortality. In particular premature
infants have widespread burn like dermatitis and increased chance of
dissemination. The risk factors for systemic dissemination are birth weight
<1500gm, extensive instrumentation during labour and broad spectrum
antibiotics. The presence of burn like dermatitis, respiratory distress, altered
liver enzymes, signs of sepsis and positive blood, urine or CSF culture strongly
indicates systemic dissemination. KOH  preparation of the scraping from skin
specimens  reveals budding yeasts and pseudohyphae.[56,57]
Neonatal candidiasis may present few days later usually acquired from
vaginal infection of the mother. Amniotic fluid is clear. There is no systemic
dissemination and the prognosis is good.[58].
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Chronic mucocutaneous candidiasis
This is characterized by persistent candidal infection of the skin, nails
and mucosa starting in infancy or early childhood and not responding to
conventional treatment .[59]
           The clinical features include persistent oral thrush, cutaneous
candidiasis with chronic intertriginous lesions, gross hyperkeratosis and deep
dermal nodules or small macules and nail changes like paronychia, nail plate
thickening with total dystrophy. There may also be seborrheic dermatitis,
alopecia areata and vitiligo. They are also predisposed to other infections like
human papilloma virus and dermatophytosis.[60] There are different types as
follows
? Autosomal recessive CMC usually starts in first decade with
persistent oral and nail infection with no endocrine defects. They
tend to improve with age.[61]
? Autosomal dominant CMC :These patients are severely
affected than autosomal recessive type with other infections such as
dermatophytosis .[61]
? Idiopathic CMC patients are severely affected with candida
granuloma oesophageal involvement , bronchiectasis and pulmonary
bullae. Candida granuloma refers to sheets of hyperkeratosis caused
by candida infection on the skin and scalp. The massive
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hyperkeratosis is due to defective neutrophils to destroy the
organisms[61,62].
? CMC associated with endocrinopathy: Mutations in
autoimmune regulator gene is found in the patients .Mutations in
autoimmune regulator gene has been proposed. In APECED
syndrome (autoimmune polyendocrinopathy, candidiasis and
ectodermal defects) is attributed to defect in AIRE (autoimmune
regulator) gene that is classically expressed in thymic cells,
monocytes, macrophages and dendritic cells.[63] The condition is
seen in early childhood and the Candida infection may preceed the
endocrine abnormalities by 10 years. The main endocrine
abnormalities reported are hypoparathyroidism, hypoadrenalism and
rarely hypothyroidism. Other abnormalities include vitiligo,
pernicious anemia and ovarian failure.
? Late onset CMC in adults may progress to develop thymoma
and SLE in later life.[64]
Various immunological abnormalities like defective phagocytosis and defect in
delayed hypersensitivity are reported. Candida endocrinopathy patients have
shown raised levels of neutralizing antibodies to interferon alpha.[65]
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Candidiasis in pregnancy
            Several hormonal changes during pregnancy can predispose to
candidiasis. Candida infection of the genital tract is also associated with the
risk of chorioaminionitis, preterm labour and congenital candidiasis. The
vaginal inflammatory status not only depends on the gestational age but also on
the microbial flora . Infections like candidiasis may rise the proinflammatory
cytokines and prostaglandin synthesis predisposing to preterm delivery.
Therefore it is important to treat vaginal candidal infection promptly.[66]
CANDIDIASIS AND HIV
         Candidiasis is the most common opportunistic infection among the HIV
patients. Oral candidiasis accounts for the majority of the infections.
Pseudomembranous and erythematous type are specifically supposed to be
markers of immunosuppression as indicated by the CD4 count less than 200
cells/cu.mm.[67] Therefore these oral manifestations may be used as an
alternative to CD4 counts with good sensitivity, better specificity and positive
predictive value in field based settings in developing countries.[68] Amongst the
different patterns pseudomembranous candidiasis has the highest specificity.
The presence of oral candidiasis can be used as a parameter to initiate ART and
as a guide for progression of disease. Patients with oral lesions with other
features of AIDS have a poorer survival rate than those without. Colonization
rates were higher in IV drug abusers . Despite some studies showing recurrent
vulvovaginal candidiasis in HIV patients, the concept of persistent infection in
these patients is less convincing.[69.70]
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SYSTEMIC CANDIDIASIS
Systemic candidiasis is a fatal condition often occurring in hospitalized
immunosuppressed patients. The predisposing factors are hematological
malignancies, neutropenia, prolonged antibiotic therapy, central venous
catheter, ablative radiotherapy, cytotoxic drugs and environmental
contamination. The infection mostly arises from the patients own GI tract. The
characteristic clinical features include fever, papular or nodular rash with an
erythematous halo and a pale center. The other skin lesions rarely reported are
ecthyma gangrenosum, nodular vasculitis like lesions, necrotic eschar, diffuse
burn like dermatitis. The presence of  triad of fever, papular rash and extreme
myalgia is a clue for systemic candidiasis [71,72]. Other organs affected are
kidneys, retina and heart valves. Candida microabscesses can occur in the
spleen and lung often called hepatosplenic candidiasis occur due to candida
microabscesses in the spleen and liver.[73]
Skin biopsy may show small aggregates of hyphae and spores in the
dermis often located at the site of vascular damage. Focal dermal necrosis,
hemorrhage and perivascular lymphocytic infilteration can be seen.
Disseminated infection may show leukocytoclastic vasculitis.[74] Trans
epidermal elimination of  Candida spores has been reported.. As systemic
candidiasis has high mortality , prompt diagnosis and treatment is mandatory.
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Candida esophagitis
Candida   species are the most common agents of fungal esophagitis.
While this is usually caused by C. albicans, other species such as C. tropicalis,
C. krusei and C. stellatoidea have also been involved. Risk factors for Candida
esophagitis have been documented in several series.[77,78] These include
pharmacological suppression of gastric acid production , use of antibiotics,
previous vagotomy, functional or mechanical esophageal abnormalities, and
endocrine diseases such as diabetes mellitus, hypothyroidism and
hypoparathyroidism. Malnutrition, alcoholism, advanced age, and therapy with
corticosteroids, either systemic or inhaled, have also been implicated.[79,80] The
blood vessels below the esophageal membranes of the AIDS patients are
eroded by Candida albicans and thus become so fragile that they bleed
easily.[80]
OCULAR CANDIDIASIS
Candida species can affect both the outer and inner eye. Infection may
originate from hematogenous dissemination or from direct fungal introduction,
the former, generally resulting in inner eye infection and the latter in clinical
manifestations of the outer parts of the eye. Both the categories of eye
involvement is caused by C.albicans and some other Candida species, such as
C.parapsilosis, C.krusei and C.glabrata.
           Outer eye involvement include conjunctivitis, keratitis, blepharitis or
lacrimal canaliculitis. Such infections are associated with trauma, surgery,
injury  and use of contact lenses, use of corticosteroid or other antibacterial
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treatment. Endopthalmitis  is due to hematogenous spread of fungal infection.
The infection is characterized by the presence of typical white cotton like
lesions, which  are important diagnostic criterion for disseminated infection.
LABORATORY DIAGNOSIS OF CANDIDAL INFECTION[81,82]
Direct examination
Clinical specimens from diseased skin can be collected by scraping the
affected area, materials from nails or in some instances by the use of swabs.
Specimens are subjected to wet mount examination with 10% KOH.. Gram’s
staining, Parker’s ink, lactophenol cotton blue enables easier demonstration of
fungal elements. The flurochromes like calcoflour white which has an affinity
for chitin and glucan aids the demonstration of fungus with a fluroscent
microscope . Direct KOH examination of the specimens reveal the presence of
budding yeasts and pseudohyphae. Candida glabrata does not produce hyphae
or pseudohyphae in clinical specimens.[84,85]
CULTURE
Isolation of the organism
The routine medium used for the isolation of fungi from the
mucocutaneous specimens is Sabouraud’s dextrose agar (SDA) supplemented
with antibiotics like chloramphenicol suppress the overgrowth of bacteria.
Candida from mucocutaneous samples are easily isolated in culture. Cultures
can be incubated at 280 C or at 370 C and Candida colonies will be grown with
in 2-3 days.
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Identification and speciation
The identification of Candida and its species is dependent on
? Macroscopic and microscopic morphology
? Physiological and biochemical characteristics
? Serology for antigenic identification of Candida spp
? Serotypes of the species
The macroscopic morphology of Candida species in SDA is smooth,
creamy yeasty colonies and is basically the same for all species but colonies of
C.krusei appears dry. On chromogenic agar, C.albicans, C.krusei and
C.tropicalis appear light green, pink and blue respectively.
Candida when grown in corn meal agar produces chlamydospores at
24-36 hrs. Chalmydospores which can  be intercalary or terminal are rounded,
large refractile vesicles measuring 8-12 micron arranged at the end and at the
sides.
GERM TUBE TEST (Raynold Braude phenomenon)
A germ tube is defined as  a filamentous extension from a yeast cell that
is almost half the width and 3-4 times the length of the cell.
The principle of the test is the ability of C.albicans or C.dublinensis to
produce blastospores when incubated in serum at 37°C for 2 hrs. It helps in the
presumptive identification of C.albicans or C.dublinensis. A true germ tube has
no constriction at the point of origin. Early pseudohyphae of C.tropicalis
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characteristically show a constriction adjacent to the mother cell. A new
monoclonal antibody specific for C.albicans germ tube has been described.
BIOCHEMICAL CHARACTERISATION
Candida species   utilizes carbhohydrates both Oxidation (assimilation)
and anaerobic means (fermentation). Various biochemical tests for assimilation
and fermentation are done using glucose, maltose, dextrose, lactose and
sucrose.
Sugar fermentation tests
The classic tests uses the liquid media supplemented with different
carbohydrates, a color indicator to assess pH changes to measure acid
formation and  a tool  to assess gas formation such as Durham’s tube.
There are several modifications for assessment of gas production such as
the use of semisolid media or a wax layer on the top of liquid medium.
Production of gas and not the change of color is used as an indicator of positive
fermentation.
Sugar assimilation
The ability of a particular yeast to utilize a particular carbohydrate as the
sole source of carbohydrate is the basis of commercial methods for the
identification of yeast. Various techniques such as classic Wickerson method,
auxanographic methods and commercial kits.
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SEROLOGICAL TESTS
The classical serology includes assays for detection of serum antibodies
by various modifications of the agglutination tests. Tests aimed at detecting
antibodies to candida antigens released  include gel immunodiffusion (ID) or
counter immunoelectrophoresis (CIE) to detect antibodies to candida
cytoplasmic antigens which are standardized by their protein content. Other
systems used include Enzyme linked immunosorbent assay (ELISA) or Latex
agglutination (LA) test. Generally, antigen detection is used for detection of
active infection .The use of combination of antigen detection and antibody
detection tests are helpful in diagnosing the infection in both
immunocompetent and immunosuppressed patients.
Molecular biology techniques
These techniques are based on detection of Candida DNA in body fluids
of patients involving the use of specific DNA probes. This approach became
more promising as a possible tool with the development of DNA amplification
techniques, particularly PCR.
Successful use of molecular techniques for the detection of the fungal
DNA in clinical specimens could possibly provide a sensitive means for early
diagnosis.
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THERAPY[83]
A wide variety of antifungals are effective against candidiasis. Important
factors that determine the clinical response, besides the choice of antifungals
include the extent and severity of the disease.
Topical antifungals
Topical antifungals for candidiasis include Gentian violet paint,
terconazole, ciclopiroxolamine, nystatin and hamycin. Thrush and other
mucocutaneous forms are treated with topical antifungals. Clotrimazole is
available as cream, lotion, powder, spray and troche. Clotrimazole vaginal
tablets are used for vaginal candidiasis. Other imidazole topical antifungals are
butoconazole, micanozole, tioconazole, terconazole and econazole.
Clotrimazole has little side effects and absorbed from the GI tract
poorly. Ketoconazole is available as cream.
Systemic antifungals
Fluconazole is the FDA approved drug for vaginal candidiasis and is
absorbed more completely than itraconazole and ketoconazole. It is also
available in suspension, tablet and parentral form. Ketoconazole is absorbed
when the pH<4.0 and hence may be a problem in achlorhydria patients
especially in HIV infected. The side effects of ketoconazole, itraconazole,
posoconazole and voriconazole are similar, more common being headache,
dyspepsia, diarrhea, vomiting, hepatitis and skin rash. Voriconazole cause
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reversible mild abnormal vision. Prolonged administration of azoles may
require surveillance of liver enzymes to monitor for hepatotoxicity.
Caspofungin and micafungin are approved for esophageal candidiasis. Adverse
effects include fever, nausea, infused –vein complications and vomiting
typically are mild.
Resistance to antifungals
Resistance to antifungals are due various factors like mutation
colonization with inherently resistant species and patients infected with
multiple strains. Candida krusei is inherently resistant to fluconazole. There
has been increasing reports of Candida glabrata being resistant to fluconazole.
Candida albicans is replaced by Candida dublinensis in fluconazole treated
patients. Isolates of C.dublinensis resistant to fluconazole may however  still be
susceptible to voriconazole and itraconazole.
The development of resistance during short term use of fluconazole is
not a problem although on an institutional level the widespread use of
fluconazole may shift the range of infecting species toward more resistant
species. Much research is into the resistance of the organism in the era of HIV
and other immunosuppressed states.
Candidal vaccine
Fungal vaccine development has mostly used cell wall extracts, which
contain polysaccharides that are generally poorly immunogenic, and protection
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in animal models has been controversial. In fact, antibody mediated protection
has been difficult to demonstrate because inhibitory and protective antibodies
seem to be equally induced. However, the monoclonal antibody 2G8 was
isolated and able to control infections caused by two fungi, Candida and
Cryptococcus.
The conjugation technology that has been so successful in making
immunogenic bacterial polysaccharides may be useful in the development of
universal “cross-kingdom” vaccines able to protect against multiple fungal
infections.
AIM AND OBJECTIVES
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AIM AND OBJECTIVE OF THE STUDY
BACKGROUND
Candida is an ubiquitious organism causing superficial fungal infection
that is commonly encountered in clinical practice.Yeast infections caused by
Candida is increasingly being reported worldwide. This increased incidence of
infections are attributed to immunocompromised diseases like HIV and the
development of wide range of newer immunosuppresives. A change in the
epidemiology, clinical spectrum and antifungal susceptibility has been
observed. The prompt detection of different species of yeast infections may aid
for the appropriate treatment decisions.
This study has been designed,
1. To study the age wise distribution of mucocutaneous candidiasis.
2. To study the sex wise distribution of mucocutaneous candidiasis.
3. To study the predisposing factors in individuals with
mucocutaneous candidiasis.
4. To study  the most common clinical features of  mucocutaneous
candidiasis
5. To identify the different species of candida  by culture,subculture
and appropriate biochemical tests in all patients with
mucocutaneous candidiasis.
6. To identify the common blood group susceptible to
mucocutaneous candidiasis
MATERIALS AND METHODS
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MATERIALS AND METHODS
This study was conducted in Rajiv Gandhi Government General Hospital,
Madras Medical college.
One hundred new patients with symptoms and signs  of mucocutaneous
candidiasis  attending  the OPD, Mycology section of  The Department of
Dermatology were included in the study. Culture in SDA agar, Hichrome
candida agar and biochemical tests like sugar fermentation were done for all
patients with positivity for Candida in 10% KOH examination.
INCLUSION CRITERIA
1. Patients with symptoms and signs of  mucocutaneous candidiasis.
2. Patients who test positive for Candida in KOH  examination.
3. All patients including immunosuppressed, pregnant and pediatric
age group are included.
EXCLUSION CRITERIA
1. Patients with negative results in KOH  examination.
2.  Those who are on topical for two weeks and systemic  antifungals
for four weeks prior to the study.
Informed consent was obtained from all patients for their participation in
this study. The skin and mucosal samples were collected and evaluated by
appropriate laboratory methods.
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MYCOLOGICAL EXAMINATION
Specimens from mucosal and cutaneous scrapings were examined in 10%
potassium hydroxide (KOH) solution for the presence of fungal spores, hyphae
and pseudohyphae.
Inoculation was done on Sabouraud’s dextrose agar (SDA) with
chloramphenicol (0.005mg/ml) at 370C and was observed everyday for the
growth of candidial colonies which appeared as white or cream coloured,
smooth with a yeasty odour. Hichrome media was used for species
identification which was by the production of different colours and corn meal
agar was used for detection of chlamydospores . Germ tube test was done by
incubating the colonies with human serum at 370C for two hours and observed
for the formation of germ tube under light microscope. Sugar fermentation
using glucose, lactose, sucrose, maltose and galactose were also carried out to
differentiate between the various species.
SABOURAUD’S DEXTROSE AGAR
MEDIA PREPARATION
Ingredients:
Dextrose           - 2g
Peptone            - 1g
Agar                 - 3g
Distilled water  - 100ml
pH                     -  6.5
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The ingredients were weighed accurately and then dissolved in 100 ml of
distilled water. This is  then heated gently till the boiling point of water so that
agar dissolves completely and the solution becomes homogenous. When the
media has become transparent, heating is stopped. Antibiotic chloramphenicol
is added (0.005mg/ml).
The media is then dispersed in tubes and autoclaved at 1210C for 15
minutes and the final pH is adjusted to 6.5. The sterilized media is then allowed
to cool to 500 C and then poured into sterile test tube.
HICHROME CANDIDA AGAR
Hichrome Candida agar is recommended for rapid isolation and
identification of species of Candida
Composition
                Ingredients                                              Grams/Litre
Peptic digest of animal tissue       15.0
Agar                                                                            5.0
Chloramphenicol                                                        0.5
Chromogenic mixture                                                 11.22
Dipotassium hydrogen phosphate                               1.0
Final pH                                                                       6.3+_0.2
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Constitution of the media
21.36 gms of Hichrome agar is dissolved in 500ml of distilled water. It is
then heated to boiling point to dissolve completely. The medium is cooled to
500 C and poured into sterile petri dishes.
Interpretation
Candida produces an enzyme beta-N-acetyl galactosaminidase/
hexosaminidase into the growth media which helps in identification of
Candida. Hichrome media is a selective and differential media which facilitates
rapid isolation of yeasts from mixed cultures and allows differentiation on the
basis of colonization and colony morphology.
Cultural response:
Organism Colour
C.albicans light green
C.tropicalis steel blue with pink hallow
C.krusei pink
C.parapsilosis cream colored
C.glabrata Purple
C.dublinensis dark green
C.guillermondii pale pink to purple
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SUGAR FERMENTATION
The classic tests involves liquid media supplemented with different
carbohydrates . Change of color from blue to yellow in the fermentation fluid is
considered as the indicator of positive fermentation.
Various species are identified by their difference in fermenting ability as
shown in the table below:
Species Dextrose Maltose Sucrose Lactose Galactose
C. albicans + + - - +
C.tropicalis + / v - +/v - -
C.glabrata + - - - -
C.krusei + - - - -
C.parapsilosis + - - - -
v-variable results;’+’ shows fermentation; ‘-’no fermentation
OBSERVATION AND
RESULTS
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OBSERVATION AND RESULTS
A total of 100 patients with features of  mucocutaneous candidiasis  who
tested positive for Candida in KOH mount were selected  for this study. The
minimum age group affected was a one month old infant and maximum age
group affected was 70 years (mean= 41.5 ). The maximum number of cases
were found to be in the age group of 31-50.[Table no 1]
Table no 1 :Age wise distribution
Age No of cases Total no of cases
Male Female
0-10 1 1 2
11-20 3 0 3
21-30 3 16 19
31-40 2 22 24
41-50 11 14 25
51-60 5 9 14
61-70 2 11 13
Total 27 73 100
SEX DISTRIBUTION
There was a female predominance with 73% (n=100) and males
were 27% (M:F ratio 1:2.7) . Maximum number of females were in the
age group of 31-40yrs and maximum number of males were in the age group
of 41-50 yrs. [Table 2]
Table no.2:Sex distribution(n=100)
Males Females
27 73
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CLINICAL PATTERNS:
 In this study, mucosal candidiasis was found in 82 patients and 18
patients had cutaneous candidiasis.
          Oral candidiasis was detected  as the most common clinical presentation
in 48 patients. Of the 48 patients with oral candidiasis, 18 were males and 30
were females. It wasfound that pseudomembranous pattern of candidiasis was
present in 30 patients (62.5%) followed by angular cheilitis (perleche) in 10
patients (20.8%) and acute erythematous type in 8 patients (16.7%). A single
patient with multicentric reticulohistocytosis who was on prolonged steroids
initially presented with acute erythematous type of oral candidiasis and
subsequently developed esophageal candidiasis. Acquired  immunodeficiency
disorder was found in 3 patients (6.25%) of which 2 patients had
pseudomembranous type and one patient had perleche.
Next to oral candidiasis, vulvovaginal candidiasis was the common
clinical pattern in mucocutaneous candidiasis in 32%.Intertriginous lesions
were noted in various sites like groin in of patients 13%, finger webspaces
(2%), toe cleft (2%) and neck (1%). Balanoposthitis was present in 2% of
patients [Table no 3&]. Recurrent vulvovaginal candidiasis were found in
about 18.75% (6/32). All six patients were diabetic [Table3,4].
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Table no 3: Clinical patterns n=100
Clinical presentation M  F Total no of cases
Oral candidiasis 18 30 48
Vulvovaginal candidiasis - 32 32
Intertrigo groin 3 10 13
Intertrigo webspace 1 1 2
Intertrigo toe cleft 2 - 2
Balanoposthitis 2 - 2
Intertrigo neck 1 - 1
Table no 4 :Patterns of oral candidiasis n=48
Type of lesion No of cases
Pseudomembranous candidiasis 30
Angular cheilitis 10
Acute erythematous type 8
Predisposing factors
In this study, there were 67 immunosuppressed individuals and 33  were
immunocompetent. Immunosuppression was the major predisposing factor.
Among the immunosuppressed, 52 patients (77.61%) had diabetes mellitus, 29
patients (43.28%) were on immunosuppressives for various conditions like
pemphigus vulgaris, bullous pemphigoid, Systemic lupus erythematoses,
multicentric reticulohistiocytosis, pustular psoriasis and  post renal transplant
state. Two of them had chronic renal failure [Table no 5]. All diabetic patients
had their random blood sugar level  in the range of 200-290 mg/dl. The diabetic
status of 50% of patients were on steroids induced.
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In oral candidiasis, the most common predisposing factor was found to
be immunosuppression in 34 patients. In 20 patients (58.8%), diabetes was the
predominant cause for immunosuppression followed by intake of
immunosuppressive drugs like steroids and cytotoxic drugs for conditions like
post renal transplant state, systemic lupus erythematosus and pustular psoriasis.
Other associated dermatological diseases  were mostly  bullous disorders like
pemphigus vulgaris in 17 patients (35.4%), systemic lupus erythematosus in 3
patients, one patient in each of pustular psoriasis multicentric
reticulohistiocytosis and erythroderma. Diseases like carcinoma cheek and
cholecystitis were also found in one patient each.
In vulvovaginal candidiasis, about 27 patients (84.4%) were diabetic and
5 patients (15.6%) were normal. Diabetes was found to be the common cause
of immunosuppression. One patient was in her second trimester of pregnancy
with gestational diabetes.
In patients with intertriginous lesions of the groin, the predisposing
factors like obesity, excessive sweating, hot humid climate and poor personal
hygiene were noted. Intertrigo of finger web spaces and toe cleft were due to
prolonged immersion in water.
Species distribution
Of the 100 patients, 45% of isolates were found to be C.tropicalis
followed by Candida albicans in 37%, C.glabrata in 9%, C.krusei in 8% and
C.parapsilosis in 1%. C.albicans were isolated in the younger age group in the
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first decade in two patients. C.parapsilosis was isolated from an elderly
diabetic female. Between 31-50 yrs, C.tropicalis was found in 22 patients
followed by C.albicans in 20 patients.[Table 5]
In oral candidiasis, C. tropicalis was the predominant organism in
20 patients (41.7%) followed by C.albicans in 19 (39.6%), C.glabrata in
6 patients (12.5%) and C.krusei in 3 patients (6.2%). [Table 6]
In vulvovaginal candidiasis, the predominant organism isolated was
C.tropicalis accounting for about in 17 patients (53.1%) followed by
C.albicans in 10 patients (31.2%), C.glabrata in 3 patients (9.5%)
,C.parapsilosis and C.krusei in one patient each (3.1%). C.tropicalis was
isolated from a pregnant female with vulvovaginal candidiasis in the third
trimester who also had gestational diabetes. In two cases of balanoposthitis,
C. albicans and C.tropicalis were isolated.
In patients with intertrigo groin, Candidia tropicalis was isolated in 5
patients (38.5%) followed by C.albicans in 5 patients (38.5%), C.krusei in  3
patients (23%).   In two cases of intertrigo toe cleft, C.krusei and C.albicans
were isolated. In two cases with intertrigo webspace, C.tropicalis was isolated.
We also found that Candidiasis was predominantly found in immune
compromised individuals in about 67%  patients and 33% of immunocompetent
individuals. Overall, 63% of  isolates were nonalbicans species and 37% were
albicans species. Out of the immune suppressed individuals, C.albicans
species in 21 patients (31.3%), C.tropicalis in 30 patients (44.8%), C.glabrata
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in 9 patients (13.4%), C.krusei in 6 patients (9%) and C.parapsilosis in one
patient (1.5%). In non immunosuppressed, C.albicans was isolated in 16
patients (48.5%), C.tropicalis in 15 patients (45.5%), C.krusei in 2 patients
(6%) [Table 5,6,7&8]
TABLE 5:Overall species distribution
Species No of cases
C .tropicalis 45
C .albicans 37
C .glabrata 9
C .krusei 8
C .parapsilosis 1
TABLE 6:Clinical pattern and the species distribution
Species OC VVC BP IG INTWS INTTC INTN
C.tropicalis 20 17 1 5 2 - -
C.albicans 19 10 1 5 - 1 1
C.glabrata 6 3 - - - - -
C.krusei 3 1 - 3 - 1 -
C.parapsilosis - 1 - - - - -
Total 48 32 2 13 2 2 -
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Table-7:Species distribution between immunosuppressed and
nonimmunosuppressed
Species Immunosuppressed Nonimmunosuppressed
C .albicans 21 16
C .tropicalis 30 15
C .glabrata 9 -
C .krusei 6 2
C.parapsilosis 1 -
Total 67 33
OC-oral candidiasis; VC-vulvovaginalcandidiasis; INT.N-intertrigoneck; INT
WS-intertrigowebspace; INT TC-intertrigo toe cleft; BP-balanoposthitis.
Table-8:Species distribution among different age groups
Age C.albicans C.tropicalis C.glabrata C.krusei C.parapsilosis
1-10 2 - - - -
11-20 - 2 1 - -
21-30 7 8 3 1 -
31-40 9 11 1 3 -
41-50 11 11 - 3 -
51-60 4 7 2 1 -
61-70 4 6 2 - 1
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Blood group and Candidiasis
We found that ‘O’ positive individuals showed higher candidal infection
in about 70% followed by ‘B’ positive blood group in 20%, ‘A’ positive in 8%,
‘O’ negative and ‘AB’ negative in 1% each. O blood group developed oral
candidiasis in 32 patients (45.7%) followed by vulvovaginal candidiasis in
20 patients(28.5%), intertrigo groin in 11 patients (15.7%), balanoposthitis,
intertrigo web space, intertrigo toe cleft in 2 patients each (2.9%) and intertrigo
neck in1 patient (1.4%). ‘B’ group had oral candidiasis in 10 patients (50%)
followed by vulvovaginal candidiasis in 8 patients (40% ) and intertrigo groin
in 2 patients (10%). [Table 9,10]
Table 9-Blood group distribution
BLOOD GROUP NO OF CASES
O+ 70
B+ 20
A+ 8
O- 1
AB- 1
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Table no 10Blood group and Candidiasis
Clinical type O+ B+ A+ AB- O-
OC 32 10 5 - 1
VVC 20 8 3 1 -
INT G 11 2 - - -
INT WS 2 - - - -
INT TC 2 - - - -
BP 2 - - - -
INT N 1 - - - -
OC-oral candidiasis; VVC-vulvovaginal candidiasis;INT.N-intertrigo neck;
INT WS-intertrigo webspace; INT TC-intertrigo toe cleft; BP-balanoposthitis
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DISCUSSION
In this study of 100 patients with mucocutaneous candidiasis, maximum
number of patients were in the 4th and 5th decade of life. The minimum age of
presentation was a one month old infant and the maximum age was 70 years.
This implies that candidiasis can affect any age group.
           In the present study, immunosuppressed patients (67%) developed
candidiasis more than the immunocompetent individuals (33%). Drezen et al,
Hawking et al proposed candidiasis to be the commonest mycoses in
immunosuppressed patients [85,86] Most of the immunosuppressive patients
(77.61%) in this study were diabetics. Safia et al, Reeding et al proposed
diabetes to be the predisposing factor for various fungal infections especially
Candida spp[87,88]
           Oral candidiasis (48%) has been observed the most common
manifestation of mucocandidiasis  in this study. Females (62.5%) had higher
occurrence than males (37.5%). Shaheen et al and Bart et al showed higher
number of males than females in contrast to this study.[89,90]  There were more
number of patients in the age group of  31-50. Zaremba et al observed
maximum no of  patients in the age group of 33-44 yrs.[91] Bezali et al   have
speculated that oral carriage cannot be directly related to age.[92]
Immunosuppression was found to the major cause in 70.8% of patients with
oral candidiasis. Among the immunosuppressed, diabetes was found in 58.8%
patients. This is similar to the study by Shaheen et al who noted the prevalence
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of oral candidiasis to be higher in immunosuppressed individuals.[89] Tapper
Jones et al, Aly et al and Abu Elteen et al reported the prevalence of yeast
carriage in diabetic individual to reach upto 54%.[93,94,95] In this study it was
found that all patients had type II diabetes and their blood sugar levels were
between 200-290 mg/dl. The relationship between the blood glucose level and
carriage rate of Candida is controversial. Hill et al proposed that long duration
of diabetes rather than diabetes by itself puts the patient at risk of oral
candidiasis [96] Gray et al proposed that there is no correlation between
glycemic level and the Candida carriage rate.[97]  Yet  another study by Lamey
et al showed the lack of association between HbA1c or blood glucose level and
the Candida carriage rate[98]. Similar reports were also given by Kumar et al
who stated that glycemic control and antidiabetic drugs have no correlation
with the Candida carriage[99].
Of the diabetic patients, Candida albicans was isolated in 40% patients
followed by Candida tropicalis in 30% patients and Candida glabrata and
Candida krusei in 15% of patients each. Candida albicans was the common
isolate which is similar to the study done by Khaled et al and Lee et al which
showed C.albicans to be more prevalent in diabetes followed by
C.tropicalis.[100,101] Tapper Jones et al showed 60% of them harbor C.albicans
and Yarahmadi et al reported higher carriage of Candida albicans in the mouth
of diabetics (40.2%) compared to controls (16.2%)[93,102]
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In this study, 37.5% of patients with oral candidiasis were suffering
from pemphigus vulgaris. Oral candidiasis occurred as a complication of
steroids. Pemphigus was shown to be associated with oral candidiasis in 24%
in a study by Shaheen et al.[89]
Among the clinical patterns of oral candidiasis, pseudomembranous
candidiasis was found to be the most common manifestation seen in 62.5%
patients followed by angular cheilitis in 20.8% patients, erythematous type in
16.7% patients. Similar observations were made by Shaheen et al and Gravina
et al who also observed pseudomembranous type as the most common clinical
pattern. [89,103]The species isolated in this study are Candida tropicalis in 41.7%
patients followed by C.albicans in 39.6% patients, C.glabrata in 12.5%
patients and Candida krusei in 6.2% patients. They were isolated in
comparable rates to C. albicans in the present study. C.albicans and
C.tropicalis were reported in equal proportion by Kamat et al, Kumar et al and
Ariyawardana et al[104,105,106]. This is in contrast to other studies which showed
C.albicans as the most common isolate (Shaheen et al, Zaremba et al)[89,91].
In this study 6.25% of patients with HIV infection presented with oral
candidiasis. All three patients had their CD4 counts were between 374-400
cells /mm3. Bodhade   et al and Campo et al proposed that oral manifestations
were common in HIV patients with CD4 counts less than 200 cells /mm 3
.[68,107]The presence of  oral candidiasis in HIV patients in this study could be
due to other contributing factors like poor oral hygiene and the prolonged use
55
of antibiotics for prevention of opportunistic infection. The number of patients
in this study is small to establish a correlation with the CD4 count and the
severity of oral candidiasis. Among the HIV patients of this study, 66.7% had
pseudomembranous candidiasis and 33.3% of patients had angular cheilitis.
Pseudomembranous candidiasis is found to be common in HIV patients in
other reports by Gravina et al and Ranganathan et al.[103,108] Erythematous
candidiasis was reported to be common in studies by Bodhade et al, Sharma et
al and Moniaci et al.[107,109,110]
C.albicans was isolated in 66.7% patients and C.tropicalis in 33.3%
patient. This is similar to a study by Ranganathan et al who reported
C. albicans as the common agent followed by C.tropicalis[108]. In HIV
patients, rise of nonalbicans species has been reported earlier by Baradkar et al
(30%)[111]and Kaviarasan et al. (20.2%)[112]. As the sample size in the present
study are small, the results are not comparable with the previous studies.
Vulvovaginal candidiasis (VVC) was found in about 32% of  patients.
In this study it was observed that vulvovaginal candidiasis is  more common in
third to fifth decade. Similar observation was made in an Indian study by Jindal
et al who described increased incidence of VVC in second to fourth decade and
he attributed it to the peak sexual activity during this age.[113]. Among the
patients with VVC, 84.4 % of patients were diabetic and 15.6% were normal.
All patients had type II diabetes. Leon et al reported 61% diabetic patients with
VVC which is lesser than the present study.[114]Overall, C.tropicalis was
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isolated in 53.1% followed by C.albicans in 31.2%, C.glabrata in 9.5%,
C.krusei and C.parapsilosis in 3.1% each. Among the diabetic patients,
organisms isolated were C.tropicalis in 63% patients followed by C.albicans in
18.5% patients, C.glabrata in 11.1% patients, C.krusei and C.parapsilosis in
3.7% patient each. In contrast, Jindal et al  reported C.albicans to be common
in 74.4% followed by nonalbicans species (25.6%) in the order of C.glabrata
(11%), C.tropicalis (5.6%), C.krusei(3.6%), C.parapsilosis and C.guillermondi
in equal proportion (2.3%).[113] Similar observation was made by Vermitzky et
al describing C.albicans to be common and C. glabrata to be the second
commonest isolate.[115]C.glabrata was commonly isolated in diabetic
individuals by Goswami et al.[116] In all the immunocompetent patients
(15.6%), C.albicans was isolated. A single pregnant female with gestational
diabetes presented with vulvovaginal candidiasis from whom C.tropicalis was
isolated
In this study, recurrent VVC was found in 18.75% of females between
the age group of 30-40 yrs. Recurrent VVC is known to occur in 5-8% of
women (Vermitzky et al).[115] Sobel et al described recurrent VVC in the age
group of 21-44 yrs which is similar to the present study.[117] The common
organism isolated was C.tropicalis in  50% of patients followed by C.albicans
in 33.3% patients and C.glabrata in 16.7%  of patients. Ritcher et al described
C.albicans to be the most common in recurrent VVC followed by
C.glabrata.[118]
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Balanoposthitis was observed in 2% of patients. One of them was a
diabetic and other was normoglycemic. C.albicans and C.tropicalis was
isolated from them. Intertriginous lesions of the groin were more common in
females (76.9%) than males (23.1%). The predisposing factors in these patients
were found to be hot humid climate, excessive sweating  and obesity. Intertrigo
of the finger web spaces and the toe cleft were observed in 2% each. Prolonged
immersion in water was the predisposing factor noted in these patients.
           In the present study, patients with O blood group (70%) had higher
occurrence of candidiasis than other blood groups (30%). O blood group
developed oral candidiasis in 45.7%. Burford et al proposed higher carriage of
Candida in patients with O blood group.[119]
           Overall in the present study, 63%of the isolates were non albicans
species and 37% was C.albicans. The nonalbicans species that were isolated in
the present study are C.tropicalis in 45% followed by C.glabrata (9%),
C.krusei(8%) and C.parapsilosis (1%). C.tropicalis was isolated in 45% which
is higher than C.albicans (37%). C.tropicalis and C.albicans were isolated in
equal proportion in oral candidiasis by Kamat et al, Kumar et al and
Ariyawardana et al[104,105,106] Further, in the present study C.glabrata has been
isolated exclusively in immunosuppressed individuals in mucosal candidiasis .
C.krusei was isolated almost in equal proportion in mucosal and cutaneous
samples. In the present study, C.parapsilosis was isolated in 3.1% of  patients
with vulvovaginal candidiasis. Bauters et al described isolation of
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C.parapsilosis in 8.9% of vaginal candidiasis patients.[120] The isolation of
C.tropicalis higher than C.albicans has not been reported in mucocutaneous
samples. But there have been increasing reports of C.tropicalis in other sites
such as blood stream and urine samples. Blood stream infections by
C.tropicalis more than C.albicans has been reported by Kothari et al,
Shivprakasha et al and Adhikari et al [121,122,123] C.tropicalis higher than
C.albicans has been reported in neonatal septicemia by Rani et al.[124] These
reports imply an increase in the incidence of nonalbicans species especially
C.tropicalis in Indian subcontinent. This unexplained increase of this species
had led many researchers to undertake DNA studies. Dassanayake et al has
demonstrated the evolutionary divergence of distinct genetic subgroups in
C.tropicalis using DNA finger printing studies.[125]
ORAL CANDIDIASIS
Pseudomembranous type with angular cheilitis
Plaque type of oral candidiasis
ORAL CANDIDIASIS IN HIV PATIENT –
Pseudomembranous type with angular cheilitis
Pseudomembranous type in a patient on prolonged steroids
VULVOVAGINAL CANDIDIASIS
VULVOVAGINAL CANDIDIASIS WITH
INTERTRIGO GROIN
INTERTRIGO FINGER WEB SPACE
INTERTRIGO TOE  CLEFT – EROSIO
INTERDIGITALIS BLASTOMYCETICA
Balanoposthitis in a diabetic patient
Intertrigo Neck- with perleche in an infant with
Nephrotic syndrome
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CONCLUSION
? Mucocandidiasis can occur in all age groups with majority of the
affected individuals in the age group of 31-50 years.
? Females outnumbered the males and the male  to female ratio was 1:2.7
? Mucocandidiasis was more common in immunosuppressed individuals
than immunocompetent individuals.
? Mucosal  candidiasis was more common than cutaneous candidiasis.
? Oral candidiasis was the most common clinical presentation followed by
vulvovaginal candidiasis.
? Among the patients with oral candidiasis, pseudo membranous type was
the most common presentation. The common predisposing factor was
found to be immunosuppression. Candida albicans and Candida
tropicalis were isolated in almost equal proportion in oral candidiasis.
? Vulvovaginal candidiasis was more common among the
immunosuppressed individuals. Candida tropicalis was isolated in
higher number than Candida albicans.
? Nonalbicans species were isolated in higher number than albicans
species.
? The nonalbicans species isolated were C.tropicalis, C.glabrata, C.krusei
and C.parapsilosis.
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? Patients with O blood group had higher occurrence of mucocutaneous
candidiasis.
? In this study, C.tropicalis was isolated in higher number than
C.albicans. Further studies in a larger population would provide more
conclusive information on the changing trends in the epidemiology of
candidal infections and would aid in the optimal treatment of patients.
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SUGAR FERMENTATION TESTS
Candida albicans
Dextrose, Sucrose , Maltose-fermented ; Lactose – not fermented
Candida parapsilosis
Dextrose - not fermented ; Lactose, Sucrose, Maltose - fermented
D- Dextrose, S- Sucrose, M- Maltose, Ga-Galactose ; Blue – not fermented ;
Yellow – fermented
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M - Male
F - Female
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MRH - Multicentric reticulohistiocytosis
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A CLINICOMYCOLOGICAL STUDY OF
MUCOCUTANEOUS CANDIDIASIS
ABSTRACT
Background : Candida is an  ubiquitious  organism causing superficial fungal
infection that is  commonly encountered in clinical  practice.   The knowledge of the
change in the epidemiology, clinical spectrum and antifungal susceptibility may aid
for the appropriate treatment decisions.
Aim and Objective : This study has been designed to study the age wise & sex wise
distribution, the predisposing factors, the common clinical features, different species
of candida and common blood group susceptible to mucocutaneous candidiasis.
Materials and Methods : One hundred patients with symptoms and signs of
mucocutaneous candidiasis attending the OPD, Mycology section of the Department
of Dermatology  were included in the study. Culture in SDA, subculture in
Hichrome agar and sugar fermentation tests were done for  all patients with
positivity for  candida in 10% KOH examination.
Results : The minimum age group affected was a one month old infant and
maximum age group affected was 70 years female. The maximum number of
patients were in the age group of 31 – 50 years with mean age 41.5 years. There was
female predominance with 73% and males were 27%. The male to female ratio was
1:2.7. Mucosal candidiasis was found in 82 patients and 18 patients had cutaneous
candidiasis. Oral candidiasis was detected in 48 patients, followed by Vulvovaginal
candidiasis in 32 patients, Balanoposthitis, intertrigo toe cleft and intertrigo finger
webspace in 2 patients each.Pseudomembranous candidiasis was present in 30
patients (62.5%), followed by angular cheilitis 10 patients  (20.8%) and acute
erythematous type in 8 patients (16.7%). Immunosuppression was the major
predisposing factor found in 67% of patients. Among the immunosuppressed, 52
patients  (77.61%) had  diabetes mellitus. Nonalbicans species was isolated in 63%
and albicans in 37%. Of the nonalbicans species, C.tropicalis was isolated in 45
patients followed by C.glabrata in 9 patients, C.krusei in 8 patients and
C.parapsilosis in 1 patient.  `O’ blood group patients had higher occurrence of
mucocutaneous candidiasis.
Conclusion : In summary, maximum number of patients were in the 4th and  5th
decade with females outnumbering the male patients. Mucosal candidiasis were
more common than cutaneous candidiasis. Nonalbicans species were the most
common isolate of which C.tropicalis were isolated in higher number than
C.albicans. However, further studies in larger population would provide conclusive
information on the changing epidemiology of  mucocutaneous candidiasis.
Key words : Mucocutaneous candidiasis, oral candidiasis, vulvovaginal candidiasis,
nonalbicans spp, C.tropicalis, C.albicans.
